Authors: Villalona-Calero, MA Eder, JP Toppmeyer, DL Allen, LF Fram, R Velagapudi, R Myers, M Amato, A Kagen-Hallet, K Razvillas, B Kufe, DW Von Hoff, DD Rowinsky, EK

Citation: Ma. Villalona-calero et al., Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignancies, J CL ONCOL, 19(3), 2001, pp. 857-869

Authors: Vonderheide, RH Dutcher, JP Anderson, JE Eckhardt, SG Stephans, KF Razvillas, B Garl, S Butine, MD Perry, VP Armitage, RJ Ghalie, R Caron, DA Gribben, JG

Citation: Rh. Vonderheide et al., Phase I study of recombinant human CD40 ligand in cancer patients, J CL ONCOL, 19(13), 2001, pp. 3280-3287

Authors: Anderson, JE Tefferi, A Craig, F Holmberg, L Chauncey, T Appelbaum, FR Guardiola, P Callander, N Freytes, C Gazitt, Y Razvillas, B Deeg, HJ

Citation: Je. Anderson et al., Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis, BLOOD, 98(3), 2001, pp. 586-593